Followers | 104 |
Posts | 2500 |
Boards Moderated | 0 |
Alias Born | 12/02/2016 |
Thursday, September 21, 2017 4:13:26 PM
What I've understood after listening to last week's Parliament hearing, is that South Africa has gone through much of the due process, and is consequently now positioned to reschedule/down-schedule cannabis within the next few weeks.
https://drive.google.com/file/d/0B4WJojoiFSszTVE5UERWdFAxWmc/view
Upon the SA governmental ratification, according to the founder of SACCRA Jason Sean O'Donoghue, Plandai SA/Protext Pharma is expected to "gain access" to a research and development license that will allow for the company to employ its proprietary technology to produce a pharmaceutical grade non-psychoactive cannabis product under license from America. IMO, the implications of South Africa down-scheduling cannabis are profound for $TXTM. It will be interesting to see what unfolds over the next few weeks.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM